Archive for September 16th, 2009

Elevated Stock/Options Volume Ahead of Oracle Earnings (ORCL)

Oracle Corp. (NASDAQ: ORCL) has already seen 150% of a full average daily trading volume ahead of today’s earnings and it is not even 1:00 PM EST.  As of 12:35 AM EST we have seen almost 43 million shares trade hands and the average volume is about 29.7 million shares.  Shares are also down 2.4% [...]

Flextronics & Cramer Shine on EMS (FLEX, CLS, SANM, JBL)

Flextronics International Ltd. (NASDAQ: FLEX) is surging this morning after a Jim Cramer tout last night on CNBC’s MAD MONEY after he said that the EMS operation is trading at just 12 times 2011 earnings and said he’s a buyer of FLEX.  At 9:02 AM EST we have shares trading up 9% at $7.54 on [...]

Omniture Leads All in Volume (OMTR, ADBE)

Omniture, Inc. (NASDAQ: OMTR) is the pre-market leader after getting acquired by Adobe Systems, Inc. (NASDAQ: ADBE).  This one closed at $17.33 yesterday and is up almost 25% at $21.60 on pre-market volume of over 4 million shares as of 8:56 AM EST.  As this is a buyout, that is of little surprise.  But acquirer [...]

American Capital Sees Flurry After Sale (ACAS, GLW)

American Capital Ltd. (NASDAQ: ACAS) is surging forward and onward this morning after Corning Incorporated (NYSE: GLW) announced that it has acquired all the shares of Axygen BioScience, Inc. and its subsidiaries from American Capital for approximately $400 million in cash.  This is after ACAS already announced some portfolio sales this week, but this is [...]

Citi Regaining Ground (C)

Citigroup, Inc. (NYSE: C) is still launching higher.  At 8:43 AM EST we have already seen over 12 million shares trade hands and shares are up 2.5% at $4.24.  For some color on how this has traded, the high yesterday during the day was $4.51, and it was $4.57 the day before.  The highs of [...]

AEterna Zantaris & Keryx Ramping (AEZS, KERX)

AEterna Zentaris Inc. (NASDAQ: AEZS) is surging on word that Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), its partner and licensee for perifosine in the North American market, received an FDA orphan-drug designation for this compound for the treatment of multiple myeloma.  Keryx had already announced last month that it reached agreement with the FDA over a [...]

Cell Therapeutics Ramps on New NHL Data (CTIC)

Cell Therapeutics, Inc. (NASDAQ: CTIC) is trading up again, this morning on news that it released updated 18-month follow-up clinical data for its phase III EXTEND trial of pixantrone pixantrone (BBR2778) for patients with advanced, relapsed or refractory, aggressive non-Hodgkin’s lymphoma (NHL).  This is different than its news from the E.U. filing yesterday.  CTIC said [...]

Agco Crop Burning (AGCO)

Agco Corp. (AGCO) is trading lower after it projected third-quarter results would be below analysts expectations based on what was weaker than expected international results. Shares are down about 7% this morning on the news.  As of 8:20 AM EST we have seen a 7% drop to $30.25 but volume is still rather light at [...]